New knee implant put to the test for Long-Term stability
NCT ID NCT05226689
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how stable a new type of knee replacement part (the tibial baseplate) is over time. It involves 31 people with knee osteoarthritis who are getting a total knee replacement. Researchers will use special X-rays to measure any movement of the implant between 6 months and 2 years after surgery.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
31 people
The number who actually took part.
- Started
-
Apr 2022
- Expected to finish
-
Jul 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
21 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Symptomatic osteoarthritis of the knee indicating primary unilateral total knee arthroplasty * Sufficient ligamentous function to warrant retention of the posterior cruciate ligament * Aged 21 years or older * Patients willing and able to comply with follow-up requirements and self-evaluations * Ability to give informed consent Exclusion Criteria: * Active or prior infection * Medical condition precluding major surgery * Known medical condition limiting patient life expectancy to \< 2 years * Expected to receive contralateral TKA within 1 year * Inflammatory arthropathy * Prior patellectomy * PCL deficiency * Major (\>25 degree) coronal plane deformity * Bilateral coronal plane deformity requiring simultaneous bilateral TKA * Bone defects requiring augments, cones and/or stemmed implants * Body Mass Index greater than 40
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Knee osteoarthritis are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Concordia Hospital
Winnipeg, Manitoba, R2K 3S8, Canada
-
London Health Sciences Centre
London, Ontario, N6A 5W9, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Custom knee guides put to the test in obese patients
- Can a shot of your own blood ease arthritic knees?
- 5,000 knee arthritis patients tracked to crack the treatment code
- Can a hydrogel injection ease knee arthritis pain?
- Weekly shot aims to melt away pounds in obesity fight
- Can shockwave plus injections quiet knee arthritis pain?